UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review

Frontiers in pharmacology, 2017-12, Vol.8, p.892-892

2017

Volltextzugriff (PDF)

Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003–2012

Medicina (Kaunas, Lithuania), 2017-01, Vol.53 (4), p.259-267

2017

Volltextzugriff (PDF)

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

BioMed research international, 2021, Vol.2021, p.9996193-16

2021

Volltextzugriff (PDF)

Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies

Expert review of pharmacoeconomics & outcomes research, 2016-03, Vol.16 (2), p.149-152

2016

Volltextzugriff (PDF)

European countries with small populations can obtain low prices for drugs: Lithuania as a case history

Expert review of pharmacoeconomics & outcomes research, 2011-06, Vol.11 (3), p.343-349

2011

Volltextzugriff (PDF)

Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe

Expert review of pharmacoeconomics & outcomes research, 2015-09, Vol.15 (5), p.755-758

2015

Volltextzugriff (PDF)

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

GaBI Journal, 2019-06, Vol.8 (2), p.49-70

2019

Volltextzugriff (PDF)

Trends and pattern of the utilization of cardiovascular medicines in Lithuania in 2003–2012

Acta medica Lituanica, 2014-12, Vol.21 (3), p.143-150

2014

Volltextzugriff (PDF)

Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas

Exploratory research in clinical and social pharmacy, 2023-09, Vol.11, p.100313, Article 100313

2023

Volltextzugriff (PDF)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Orphanet journal of rare diseases, 2020-10, Vol.15 (1), p.1-277, Article 277

2020

Volltextzugriff (PDF)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Frontiers in pharmacology, 2019-05, Vol.10, p.487-487

2019

Volltextzugriff (PDF)

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

Frontiers in public health, 2018-12, Vol.6, p.328

2018

Volltextzugriff (PDF)

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Frontiers in pharmacology, 2018-01, Vol.8, p.942-942

2018

Volltextzugriff (PDF)

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”

BioMed research international, 2023, Vol.2023 (1), p.9757348-9757348

2023

Volltextzugriff (PDF)

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Expert review of clinical pharmacology, 2015-01, Vol.8 (1), p.77-94

2015

Volltextzugriff (PDF)

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

Expert review of pharmacoeconomics & outcomes research, 2019-05, Vol.19 (3), p.251-261

2019

Volltextzugriff (PDF)

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Frontiers in public health, 2021-06, Vol.9

2021

Volltextzugriff (PDF)

Marked Differences in Antibiotic Use and Resistance Between University Hospitals in Vilnius, Lithuania, and Huddinge, Sweden

Microbial drug resistance (Larchmont, N.Y.), 2001-12, Vol.7 (4), p.383-389

2001

Volltextzugriff (PDF)

Healthcare professional-led interventions on lifestyle modifications for hypertensive patients – a systematic review and meta-analysis

BMC family practice, 2021-04, Vol.22 (1), Article 63

2021

Volltextzugriff (PDF)

Non-persistence to antihypertensive drug therapy in Lithuania

European journal of clinical pharmacology, 2022-10, Vol.78 (10), p.1687-1696

2022

Volltextzugriff (PDF)

One-year treatment non-persistence rates in hypertensive patients in Lithuania

Research in social and administrative pharmacy, 2022-06, Vol.18 (6), p.e5

2022

Volltextzugriff (PDF)

Trend of Antihypertensive Medicine Use in the Baltic States between 2008 and 2018: A Retrospective Cross-National Comparison

Pharmacoepidemiology, 2022-01, Vol.1 (1), p.1-11

2022

Volltextzugriff (PDF)

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Expert review of pharmacoeconomics & outcomes research, 2021-07, Vol.21 (4), p.527-540

2021

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(32)
Berichte
(3)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review

Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003–2012

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies

European countries with small populations can obtain low prices for drugs: Lithuania as a case history

Improving the managed introduction of new medicines: sharing experiences to aid authorities across Europe

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

Pricing of oral generic cancer medicines in 25 European countries; findings and implications

Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues

Trends and pattern of the utilization of cardiovascular medicines in Lithuania in 2003–2012

Hypertension management and drug-related problems. A case report of the 23-year history of Mr. Jonas

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

Marked Differences in Antibiotic Use and Resistance Between University Hospitals in Vilnius, Lithuania, and Huddinge, Sweden

Healthcare professional-led interventions on lifestyle modifications for hypertensive patients – a systematic review and meta-analysis

Non-persistence to antihypertensive drug therapy in Lithuania

One-year treatment non-persistence rates in hypertensive patients in Lithuania

Trend of Antihypertensive Medicine Use in the Baltic States between 2008 and 2018: A Retrospective Cross-National Comparison

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Suchergebnisse filtern